FDA to review 7 popular peptides touted for weight loss, healing and longevity

The FDA is reviewing seven unapproved peptides for potential inclusion in compounded prescription drugs, with meetings scheduled for July 23-24. These peptides, popular for weight loss, wound healing, and other health claims, are widely available through clinics and online sellers despite lacking FDA approval. HHS Secretary Robert F. Kennedy Jr. supports expanding access, while FDA reviewers express concerns about safety and efficacy.